Clinical Studies

Ongoing Studies

NYX-2925

Phase 2 –¬†Fibromyalgia (Exploratory)

A Single-Blind, Exploratory, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Daily Oral NYX-2925 in Subjects with Fibromyalgia¬†— For more information, visit¬†www.clinicaltrials.gov